196 related articles for article (PubMed ID: 20217214)
1. Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells.
Petersson S; Shubbar E; Yhr M; Kovacs A; Enerbäck C
Breast Cancer Res Treat; 2011 Jan; 125(1):13-25. PubMed ID: 20217214
[TBL] [Abstract][Full Text] [Related]
2. The expression of Psoriasin (S100A7) and CD24 is linked and related to the differentiation of mammary epithelial cells.
Vegfors J; Petersson S; Kovács A; Polyak K; Enerbäck C
PLoS One; 2012; 7(12):e53119. PubMed ID: 23300877
[TBL] [Abstract][Full Text] [Related]
3. Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development.
Carlsson H; Petersson S; Enerbäck C
Int J Oncol; 2005 Dec; 27(6):1473-81. PubMed ID: 16273201
[TBL] [Abstract][Full Text] [Related]
4. S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells.
Petersson S; Bylander A; Yhr M; Enerbäck C
BMC Cancer; 2007 Nov; 7():205. PubMed ID: 17986321
[TBL] [Abstract][Full Text] [Related]
5. A putative role for psoriasin in breast tumor progression.
Krop I; März A; Carlsson H; Li X; Bloushtain-Qimron N; Hu M; Gelman R; Sabel MS; Schnitt S; Ramaswamy S; Kleer CG; Enerbäck C; Polyak K
Cancer Res; 2005 Dec; 65(24):11326-34. PubMed ID: 16357139
[TBL] [Abstract][Full Text] [Related]
6. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
[TBL] [Abstract][Full Text] [Related]
7. Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation.
Shubbar E; Vegfors J; Carlström M; Petersson S; Enerbäck C
Breast Cancer Res Treat; 2012 Jul; 134(1):71-80. PubMed ID: 22189627
[TBL] [Abstract][Full Text] [Related]
8. Psoriasin expression in mammary epithelial cells in vitro and in vivo.
Enerbäck C; Porter DA; Seth P; Sgroi D; Gaudet J; Weremowicz S; Morton CC; Schnitt S; Pitts RL; Stampl J; Barnhart K; Polyak K
Cancer Res; 2002 Jan; 62(1):43-7. PubMed ID: 11782356
[TBL] [Abstract][Full Text] [Related]
9. Psoriasin (S100A7) and calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants.
Carlsson H; Yhr M; Petersson S; Collins N; Polyak K; Enerbäck C
Cancer Biol Ther; 2005 Sep; 4(9):998-1005. PubMed ID: 16082188
[TBL] [Abstract][Full Text] [Related]
10. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation.
Martinsson H; Yhr M; Enerbäck C
Exp Dermatol; 2005 Mar; 14(3):161-8. PubMed ID: 15740587
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.
Skliris GP; Lewis A; Emberley E; Peng B; Weebadda WK; Kemp A; Davie JR; Shiu RP; Watson PH; Murphy LC
Breast Cancer Res Treat; 2007 Jul; 104(1):75-85. PubMed ID: 17009105
[TBL] [Abstract][Full Text] [Related]
14. Muc1/Cd227 immunohistochemistry in routine practice is a useful biomarker in breast cancers.
Garbar C; Mascaux C; Curé H; Bensussan A
J Immunoassay Immunochem; 2013; 34(3):232-45. PubMed ID: 23656244
[TBL] [Abstract][Full Text] [Related]
15. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer.
Emberley ED; Niu Y; Njue C; Kliewer EV; Murphy LC; Watson PH
Clin Cancer Res; 2003 Jul; 9(7):2627-31. PubMed ID: 12855640
[TBL] [Abstract][Full Text] [Related]
16. Psoriasin (S100A7) expression and invasive breast cancer.
Al-Haddad S; Zhang Z; Leygue E; Snell L; Huang A; Niu Y; Hiller-Hitchcock T; Hole K; Murphy LC; Watson PH
Am J Pathol; 1999 Dec; 155(6):2057-66. PubMed ID: 10595935
[TBL] [Abstract][Full Text] [Related]
17. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
[TBL] [Abstract][Full Text] [Related]
18. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS
J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922
[TBL] [Abstract][Full Text] [Related]
19. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
20. Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells.
Ye L; Sun PH; Martin TA; Sanders AJ; Mason MD; Jiang WG
Urol Oncol; 2013 Nov; 31(8):1576-83. PubMed ID: 22694938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
